Inhibitory effects of azelnidipine tablets on morning hypertension

Drugs in R and D

Volumn 13, Issue 1, 2013, Pages 63-73

  Kario, Kazuomi ^a   Sato, Yuki ^b   Shirayama, Masayuki ^b   Takahashi, Megumi ^b   Shiosakai, Kazuhito ^b   Hiramatsu, Katsutoshi ^b   Komiya, Masahiro ^b   Shimada, Kazuyuki ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b DAIICHI SANKYO CO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AZELNIDIPINE;

ADULT; ARTICLE; DIASTOLIC BLOOD PRESSURE; DIZZINESS; DRUG EFFECT; DRUG INHIBITION; EDEMA; FEMALE; HEADACHE; HEART PALPITATION; HOT FLUSH; HUMAN; HYPERTENSION; JAPAN; MAJOR CLINICAL STUDY; MALE; OPEN STUDY; PRIORITY JOURNAL; PULSE RATE; SYSTOLIC BLOOD PRESSURE;

AGED; AZETIDINECARBOXYLIC ACID; BLOOD PRESSURE; CALCIUM CHANNEL BLOCKERS; CIRCADIAN RHYTHM; DIHYDROPYRIDINES; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; REGISTRIES; TABLETS; TREATMENT OUTCOME;

EID: 84876214016     PISSN: 11745886     EISSN: 11796901     Source Type: Journal    
DOI: 10.1007/s40268-013-0006-8     Document Type: Article

References (24)

1. Kario K, Pickering TG, Umeda Y, et al. Morning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives: a prospective study. Circulation. 2003;107(10):1401-6.
2. Kario K, Eguchi K, Umeda Y, et al. Morning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertension. Circulation. 2003;108(10):72e-3e.
3. Pickering TG, Davidson K, Gerin W, et al. Masked hypertension. Hypertension. 2002;40(6):795-6.
4. Okubo T, Imai Y, Tsuji I, et al. Home blood pressure measurement has a stronger predictive power for mortality than does screening blood pressure measurement: a population-based observation in Ohasama, Japan. J Hypertens. 1998;16:971-5.
5. Ménard J, Chatellier G, Day M, et al. Self-measurement of blood pressure at home to evaluate drug effects by the trough:peak ratio. J Hypertens. 1994;12(Suppl 8):S21-5.
6. ++ channel blocker, in SHR [in Japanese]. Jpn J Pharmacol. 1989;51:57-64.
7. Oizumi K, Nishino H, Miyamoto M, et al. Beneficial renal effects of CS-905, a novel dihydropyridine calcium blocker, in SHR [in Japanese]. Jpn J Pharmacol. 1989;51(4):501-8.
8. Ikeda K, Nishino H, Oizumi K, et al. Antihypertensive effects of CS-905, a new calcium antagonist in cholesterol-fed rabbits [in Japanese]. Jpn J Pharmacol. 1992;58(Suppl):342.
9. Kuramoto K, Ichikawa S, Hirai A, et al. Azelnidipine and amlodipine: a comparison of their pharmacokinetics and effects on ambulatory blood pressure. Hypertens Res. 2003;26:201-8.
10. Kumagaya H, Onami T, Iigatani Y, et al. Mechanism of a reduction in heart rate by azelnidipine as investigated in terms of the peripheral and central nervous systems [in Japanese]. Prog Med (Jpn). 2004;24(11):2659-64.
11. Sega R, Facchetti R, Bombelli M, et al. Prognostic value of ambulatory and home blood pressure compared with office blood pressure in the general population: follow-up results from the Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) Study. Circulation. 2005;111:1777-83.
12. Ohkubo T, Kikuya M, Metoki H, et al. Prognosis of "masked" hypertension and "white-coat" hypertension detected by 24-h ambulatory blood pressure monitoring 10-year follow-up from the Ohasama study. J Am Coll Cardiol. 2005;46(3):508-15.
13. Kario K, Ishikawa J, Pickering TG, et al. Morning hypertension: the strongest independent risk factor for stroke in elderly hypertensive patients. Hypertens Res. 2006;29(8):581-7.
14. Kario K, Matsui Y, Shibasaki S, et al. An alpha-adrenergic blocker titrated by self-measured blood pressure and microalbuminuria in patients with morning hypertension: the Japan Morning Surge-1 Study. J Hypertens. 2008;26(6):1257-65.
15. Yamamoto Y, Sonoyama K, Matsubara K, et al. The status of hypertension management in Japan in 2000. Hypertens Res. 2002;25(5):717-25.
16. Sada T, Mizuno M, Miyama T, et al. Pharmacological characteristics of azelnidipine, a long-acting calcium antagonist, having vascular affinity (No. 2) - antihypertensive effect and pharmacokinetics in spontaneously hypertensive rats (SHR) [in Japanese]. Jpn Pharmacol Ther. 2002;30(9):711-20.
17. Sada T, Mizuno M, Oohata K, et al. Antiatherosclerotic effect of azelnidipine, a long-acting calcium antagonist with high lipophilicity, in cholesterol-fed rabbits [in Japanese]. Jpn Pharmacol Ther. 2002;30(9):721-8.
18. Yorikane R. Unique cardiac effect of azelnidipine, a novel calcium antagonist [in Japanese]. Bio Clin. 2003;18(13):1210-5.
19. Palatini P, Benetos A, Julius S. Impact of increased heart rate on clinical outcomes in hypertension: implications for antihypertensive drug therapy. Drugs. 2006;66(2):133-44.
20. Okabayashi J, Matsubayashi K, Sato T, et al. Effects of nifedipine and enalapril on the central nervous system in elderly hypertensive patients: power spectral analysis of heart rate variability [in Japanese]. Jpn J Geriatr. 1994;31(4):285-92.
21. Eguchi K, Kario K, Shimada K. Differential effects of a long-acting angiotensin converting enzyme inhibitor (temocapril) and a long-acting calcium antagonist (amlodipine) on ventricular ectopic beats in older hypertensive patients. Hypertens Res. 2002;25(3):329-33.
22. ®) tablet [in Japanese]. J Clin Ther Med. 2005;21:511-27.
23. UK Prospective Diabetes Study Group. Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39. BMJ. 1998;317(7160):713-20.
24. Nippon Data 80 Research Group. Impact of elevated blood pressure on mortality from all causes, cardiovascular diseases, heart disease and stroke among Japanese: 14 year follow-up of randomly selected population from Japanese-Nippon data 80. J Hum Hypertens. 2003;17(12):851-7.